PET-CTPROMISE CriteriaPSMA ScoreInter-Observer VariabilityAims & Objectives: Aim of the study was to evaluate inter-observer variability in interpretation of Gallium-68 labeled Prostate Specific Membrane Antigen sub-type 11 (68Ga-PSMA-11) Positron Emission Tomography-Computed Tomography PET_CT scan ...
PET/CTmiPSMA scorePSMA-RADSPSMA PET/CT emerges as a pivotal technology in the diagnostic landscape of prostate cancer (PCa). It offers a suite of imaging interpretation criteria, notably the maximum standardized uptake value (SUVmax), the molecular imaging prostate-specific membrane antigen score ...
PSMA PET/CT identified lymph-node metastasis in the left obturator region, leading to a change in the treatment plan to hormonal therapy. Recent attempts have been made to incorporate PSMA PET/CT in determining the indications
A VISION Substudy of Reader Agreement on 68Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for 177Lu-PSMA-617 Radioligand Therapy [68Ga]Ga-PSMA-11 (68Ga-PSMA-11) is used to identify prostate specific membrane antigen (PSMA)-positive tumors on PET scans. In the VISION...
zhao r, li y, nie l, et al. the meta-analysis of the effect of 68 ga-psma-pet/ct diagnosis of prostatic cancer comparedwith bone scan[j]. medicine (baltimore), 2021, 100(15):e25417. [22] dadgar h, emami f, no...
Interpretation of [68Ga]Ga-PSMA-11 PET/CT images was based on PROMISE criteria including miTNM staging and lesions miPSMA expression score visual estimation and PSMA-RADS version 1.0 for a given scan. Readers’ agreement was measured using Krippendorff’s coefficients Results Agreement between ...
EP: 9.Navigating and Overcoming Challenges of PSMA-PET Imaging Results Interpretation EP: 10.Best Practices for Communication: A Multidisciplinary Perspective EP: 11.Navigating Virtual Tumor Boards for Prostate Cancer PSMA-PET Imaging EP: 12.Unmet Needs in Imaging for Patients With Prostate Cancer EP...
Scan results differed depending on the PSA value at the time of imaging and the scanner (Table 2). The employed PET/CT system did not have an influence on changes to the case interpretation due to biphasic imaging (odds ratio 1.37, 95% confidence interval 0.78–2.42, p = 0.27). ...
Unfortunately there was no subsequent PSMA-PET/CT available for non-responding lesion 2, which was classified as partially responsive based on PSMA-positive lesion volume with a decrease of 94%. Twenty-one patients (65.6%) showed new metastases on post-treatment scan. In seven patients (21.9%)...
For the entire cohort, 118/273 (43.2%) patients had recurrent disease detected with PSMA PET scan before sRT. More specifically, 78/273 (28.6%) patients had local recurrence and 48/273 (17.6%) nodal recurrence, respectively. However, in multivariate LR, none of the clinical parameters had ...